correction to: Long-Lasting Designer Insulin with Glucose-Dependent Solubility Markedly Reduces Risk of Hypoglycemia (Adv. Therap., (2019), 2, 1, (900 128), 10.1002/adtp.201900128)

Yibo Qiu, Rahul Agrawal, Diao Chen, Nan Zheng, Griffin Durupt, Jin Hwan Kim, Simon J. Fisher, Danny Hung-Chieh Chou

Research output: Contribution to journalComment/debate

Abstract

Adv. Therap. 2019,2,1 900 128 DOI: https://doi.org/10.1002/adtp.201900128 In the original published article, Figure 6 is a duplicate of Figure 5 and the statement that the authors, Yibo Qiu and Rahul Agrawal, contributed equally is missing. The correct figure 6 is: Y. Q. and R. A. contributed equally to this work. The conclusions of the article are not affected by these errors. The authors apologize for any inconvenience caused.

Original languageEnglish
Article number2000227
JournalAdvanced Therapeutics
Volume3
Issue number12
DOIs
StatePublished - Dec 2020

Bibliographical note

Publisher Copyright:
© 2020 Wiley-VCH GmbH

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology
  • Pharmaceutical Science
  • Genetics(clinical)
  • Biochemistry, medical
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'correction to: Long-Lasting Designer Insulin with Glucose-Dependent Solubility Markedly Reduces Risk of Hypoglycemia (Adv. Therap., (2019), 2, 1, (900 128), 10.1002/adtp.201900128)'. Together they form a unique fingerprint.

Cite this